Oramed Pharmaceuticals (ORMP) Competitor Comparison
We are evaluating the key criteria listed to compare Oramed Pharmaceuticals (ORMP) against its competitors in the Biotechnology industry.
Market Capitalization
241 / 368Gross Profits
113 / 278Total Revenue
224 / 300EBITDA
91 / 337Free Cashflow
104 / 352Quick Ratio
279 / 357Earnings per Share
27 / 359Dividend yield
0 / 6Total Cash
171 / 358Performance 3 years
303 / 368Performance 5 years
152 / 368Performance 10 years
181 / 368Linearity 3 years
304 / 368Linearity 5 years
4 / 368Linearity 10 years
90 / 368Total Rank
219 / 368Dividend Rank
29 / 368Valuation Rank
283 / 368Piotroski Rank
218 / 368Muliplier Rank
173 / 368Dividend Rank - ORMP ranking 29 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.